Humana (NYSE:HUM) recently reported significant growth in its Q1 earnings, with revenue and net income seeing substantial increases compared to the previous year. Nonetheless, the company revised its ...

Delving into the details, we found 44% of traders were bullish, while 33% showed bearish tendencies. Out of all the trades we ...

Humana's HUM +1.79% + Free Alerts short percent of float has fallen 14.71% since its last report. The company recently ...

Beginning in 2014, the Centers for Medicare & Medicaid Services (CMS) has permitted Medicare Advantage insurers to offer ...

Humana’s profits shot up by 68% in the 2025 first quarter on higher revenues as the company continued to yield strong returns from its pharmacy, primary care and home solutions subsidiary, CenterWell.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Despite the outperformance, the payer’s stock was largely flat following the earnings release — a market reaction that ...

Humana ( HUM) reported first quarter earnings that met Wall Street expectations Wednesday. The company beat on adjusted ...

Health insurer Humana on Wednesday reported lower-than expected medical costs in the first quarter, allaying investor ...

The health insurer reported an adjusted profit of $11.58 a share, beating expectations, as revenue rose about 8% from a year ...

Humana, the second-largest Medicare Advantage insurer with 5.8 million beneficiaries, reported Wednesday that net income ...

Discover insights from Humana's Q1 2025 earnings call: growth in Medicaid, strategic investments in CenterWell, and reaffirmed $16.25 EPS guidance.